Mitochondrial Medicine: Developing New Treatments Business

This conference brings together world leaders in the field of translational mitochondrial medicine to engage.

This conference will bring together world leaders in the field of translational mitochondrial medicine in an interactive programme designed to engage and inspire a new generation of mitochondrial researchers, who will harness this new technology to prevent and treat these devastating diseases.

The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine.

Scientific sessions
- Novel mechanisms of mitochondrial disease
- Measuring clinical progression
- Disease biomarkers
- Precision medicines
- Targeted treatment
- Current active trials

A limited number of registration bursaries are available for PhD students to attend this conference (up to 50% of the registration fee) from Wellcome Genome Campus Scientific Conferences.

Bursary Deadline: 2 March 2016
Abstract Deadline: 9 March 2016
Registration Deadline: 16 March 2016

Url:

Booking: http://atnd.it/47105-1

Price
Student from: GBP 250
Academic from: GBP 350
Commercial from: GBP 450

Speakers: Mary Herbert (University of Newcastle, UK), Saskia Koene (Radboud UMC, The Netherlands), Michal Minczuk (MRC Mitochondrial Biology Unit, Cambridge, UK), Carlos Moraes (University of Miami Miller School of Medicine, USA), Michael Murphy (MRC Mitochondrial Biology Unit, Cambridge, UK), Holger Prokisch (Technische Universität München, Germany), Elena Rugarli (University of Cologne, Germany) Luca Scorrano (University of Padova, Italy), Valeria Tiranti (Foundation IRCCS-Neurological Institute C. Besta, Italy), Douglas Turnbull (University of Newcastle, UK), Alex Whitworth (MRC Mitochondrial Biology Unit, Cambridge, UK), Patrick Chinnery (University of Cambridge, UK), Marni Falk (The Children’s Hospital of Philadelphia, USA), Vamsi Mootha (Harvard Medical School, USA), Jan Smeitink (Radboud UMC, The Netherlands), Anu Suomalainen (University of Helsinki, Finland), Massimo Zeviani (MRC Mitochondrial Biology Unit, Cambridge, UK)

More details